Therefore, the decrease expression of p-YAP in primary tumor (Grade 1) when compared with normal tissue and further decease phosphorylation from grade II to III indicated the inhibition of Hippo pathway, and support it oncogenic contribution to the advance stage of NSCLC. Here, YAP1 is linked to non-small cell lung carcinoma.